Abstract

Background

There is a paucity of prognostic models for COVID-19 that are usable for in-office patient assessment in general practice (GP).

Objectives

To develop and validate a risk prediction model for hospital admission with readily available predictors.

Methods

A retrospective cohort study linking GP records from 8 COVID-19 centres and 55 general practices in the Netherlands to hospital admission records. The development cohort spanned March to June 2020, the validation cohort March to June 2021. The primary outcome was hospital admission within 14 days. We used geographic leave-region-out cross-validation in the development cohort and temporal validation in the validation cohort.

Results

In the development cohort, 4,806 adult patients with COVID-19 consulted their GP (median age 56, 56% female); in the validation cohort 830 patients did (median age 56, 52% female). In the development and validation cohort respectively, 292 (6.1%) and 126 (15.2%) were admitted to the hospital within 14 days, respectively. A logistic regression model based on sex, smoking, symptoms, vital signs and comorbidities predicted hospital admission with a c-index of 0.84 (95% CI 0.83 to 0.86) at geographic cross-validation and 0.79 (95% CI 0.74 to 0.83) at temporal validation, and was reasonably well calibrated (intercept −0.08, 95% CI −0.98 to 0.52, slope 0.89, 95% CI 0.71 to 1.07 at geographic cross-validation and intercept 0.02, 95% CI −0.21 to 0.24, slope 0.82, 95% CI 0.64 to 1.00 at temporal validation).

Conclusion

We derived a risk model using readily available variables at GP assessment to predict hospital admission for COVID-19. It performed accurately across regions and waves. Further validation on cohorts with acquired immunity and newer SARS-CoV-2 variants is recommended.

Details

Title
Development and validation of a risk prediction model for hospital admission in COVID-19 patients presenting to primary care
Author
Wynants, Laure 1   VIAFID ORCID Logo  ; Broers, Natascha JH 2 ; Platteel, Tamara N 3   VIAFID ORCID Logo  ; Venekamp, Roderick P 3   VIAFID ORCID Logo  ; Barten, Dennis G 4   VIAFID ORCID Logo  ; Mathie PG Leers 5   VIAFID ORCID Logo  ; Verheij, Theo JM 3   VIAFID ORCID Logo  ; Stassen, Patricia M 6   VIAFID ORCID Logo  ; Cals, Jochen WL 2   VIAFID ORCID Logo  ; Eefje GPM de Bont 2   VIAFID ORCID Logo 

 Department of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Department of Development and Regeneration, KU Leuven, Leuven, Belgium 
 Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands 
 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands 
 Department of Emergency Medicine, VieCuri Medical Center, Venlo, The Netherlands 
 Dept. of Clinical Chemistry & Hematology, Zuyderland MC Sittard-Geleen/Heerlen, Heerlen, The Netherlands 
 Department of Internal Medicine, School for Cardiovascular Diseases, CARIM, Maastricht University Medical Center, Maastricht, The Netherlands 
Publication year
2024
Publication date
Dec 2024
Publisher
Taylor & Francis Ltd.
ISSN
13814788
e-ISSN
17511402
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3142747650
Copyright
© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.